Regorafenib-induced hand-foot skin reaction with striking epidermal dysmaturation - a new histopathological pattern associated with the use of multi-kinase inhibitors
- PMID: 26801207
- DOI: 10.1111/bjd.14417
Regorafenib-induced hand-foot skin reaction with striking epidermal dysmaturation - a new histopathological pattern associated with the use of multi-kinase inhibitors
Similar articles
-
[Sorafenib: effectiveness versus safety. Prevention of hand-foot syndrome].Farm Hosp. 2009 Sep-Oct;33(5):288-9. doi: 10.1016/s1130-6343(09)72470-5. Farm Hosp. 2009. PMID: 19775581 Spanish. No abstract available.
-
Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.Br J Dermatol. 2008 Mar;158(3):592-6. doi: 10.1111/j.1365-2133.2007.08357.x. Epub 2007 Dec 6. Br J Dermatol. 2008. PMID: 18070211
-
[Hand-foot syndrome and sorafenib].Bull Cancer. 2009 Feb;96(2):191-7. doi: 10.1684/bdc.2008.0814. Bull Cancer. 2009. PMID: 19258226 French.
-
Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x. Dermatol Ther. 2011. PMID: 21910797 Review.
-
[Hand-foot syndrome after administration of tyrosinkinase inhibitors].Klin Onkol. 2010;23(5):300-5. Klin Onkol. 2010. PMID: 21061680 Review. Czech.
Cited by
-
Identification of Keratinocyte Cytoprotectants against Toxicity by the Multikinase Inhibitor Sorafenib Using Drug Repositioning.JID Innov. 2024 Feb 28;4(3):100271. doi: 10.1016/j.xjidi.2024.100271. eCollection 2024 May. JID Innov. 2024. PMID: 38585194 Free PMC article.
-
Cutaneous Reaction Induced by Intramuscular Diclofenac Showing Epidermal Dysmaturation.Indian J Dermatol. 2022 Jan-Feb;67(1):65-66. doi: 10.4103/ijd.ijd_900_20. Indian J Dermatol. 2022. PMID: 35656276 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources